According to Red Herring, Zogenix, Inc., a privately held pharmaceutical company, raised $60 million to help it bring to market the Intraject® system. This needle-free, single use, pre-filled and disposable subcutaneous delivery system of sumatriptan should make the treatment of migraines easier for patients.
Check out the product page here…
The Intraject® System
August 31st, 2006 
Medgadget Editors Medicine, Neurology